These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15461311)

  • 1. Introduction to sertindole in clinical practice.
    Peuskens J
    CNS Drugs; 2004; 18 Suppl 2():1-4. PubMed ID: 15461311
    [No Abstract]   [Full Text] [Related]  

  • 2. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.
    Brown LA; Levin GM
    Pharmacotherapy; 1998; 18(1):69-83. PubMed ID: 9469684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertindole : a review of its use in schizophrenia.
    Murdoch D; Keating GM
    CNS Drugs; 2006; 20(3):233-55. PubMed ID: 16529528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine, sertindole and schizophrenia.
    Drug Ther Bull; 1997 Nov; 35(11):81-3. PubMed ID: 9464002
    [No Abstract]   [Full Text] [Related]  

  • 5. Sertindole versus haloperidol for schizophrenia.
    Balon R
    Am J Psychiatry; 1998 Sep; 155(9):1303-4. PubMed ID: 9734566
    [No Abstract]   [Full Text] [Related]  

  • 6. Sertindole versus haloperidol for schizophrenia.
    Mattes JA
    Am J Psychiatry; 1998 Sep; 155(9):1303; author reply 1303-4. PubMed ID: 9734567
    [No Abstract]   [Full Text] [Related]  

  • 7. Case histories illustrating the utility of sertindole in clinical practice.
    Schuck P; van den Ameele H; Jaanson P; Ryckmans V; Hawley C
    CNS Drugs; 2004; 18 Suppl 2():31-40; discussion 41-3. PubMed ID: 15461314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sertindole in treating schizophrenia.
    Hosp Med; 1998 Feb; 59(2):165. PubMed ID: 9797900
    [No Abstract]   [Full Text] [Related]  

  • 9. Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety.
    Tamminga CA; Mack RJ; Granneman GR; Silber CJ; Kashkin KB
    Int Clin Psychopharmacol; 1997 Feb; 12 Suppl 1():S29-35. PubMed ID: 9179641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertindole for the treatment of schizophrenia.
    Azorin JM; Kaladjian A; Fakra E; Adida M
    Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertindole in schizophrenia: efficacy and safety issues.
    Muscatello MR; Bruno A; Micali Bellinghieri P; Pandolfo G; Zoccali RA
    Expert Opin Pharmacother; 2014 Sep; 15(13):1943-53. PubMed ID: 25084209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the efficacy, tolerability and safety of sertindole in clinical trials.
    Perquin L; Steinert T
    CNS Drugs; 2004; 18 Suppl 2():19-30; discussion 41-3. PubMed ID: 15461313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of sertindole in schizophrenia: a clinical review.
    Zoccali RA; Bruno A; Muscatello MR
    J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertindole: a review of clinical efficacy.
    Kane JM
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
    Daniel DG; Wozniak P; Mack RJ; McCarthy BG
    Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug safety and efficacy evaluation of sertindole for schizophrenia.
    Karamatskos E; Lambert M; Mulert C; Naber D
    Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangle.
    Bech P; Tanghøj P; Andreasson K; Overø KF
    Acta Psychiatr Scand; 2011 Feb; 123(2):154-61. PubMed ID: 20560900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we need another atypical antipsychotic?
    Kasper S
    Eur Neuropsychopharmacol; 2008 Aug; 18 Suppl 3():S146-52. PubMed ID: 18511242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked elevation of creatine kinase with sertindole: a case report.
    Oulis P; Koulouris GC; Konstantakopoulos G; Masdrakis VG
    Pharmacopsychiatry; 2007 Nov; 40(6):295-6. PubMed ID: 18030658
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of the safety and tolerability of sertindole.
    Hale AS
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S65-70. PubMed ID: 9690973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.